# Cobenfy

NDC: 0003-0125
Generic name: xanomeline and trospium chloride
Labeler / Manufacturer: E.R. Squibb & Sons, L.L.C.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE, COATED PELLETS
Routes: ORAL
Marketing started: 20240927

FDA application: NDA216158

## Active ingredients

- TROSPIUM CHLORIDE: 30 mg/1
- XANOMELINE: 125 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0003-0125"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0003-0125
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8f0e73bf-6025-44f6-ab64-0983322de0df